Collectively, in this study, we provided evidence that YH-306 inhibited CRC cell migration, invasion and proliferation in vitro resulting in the suppression of growth and metastasis in vivo via inhibition of the FAK pathways, implying that YH-306 might be valuable in preventing CRC growth and metastasis. Here, PTK2 is linked to colorectal carcinoma.